journal article·2017-05-08Open access

Facile Preparation of Delivery Platform of Water-Soluble Low-Molecular-Weight Drugs Based on Polyion Complex Vesicle (PICsome) Encapsulating Mesoporous Silica Nanoparticle

Akinori Goto, Hung-Chi Yen, Yasutaka Anraku, Shigeto Fukushima, Ping-Shan Lai, Masaru Kato, Akihiro Kishimura, Kazunori Kataoka

Abstract

Polyion complex vesicles (PICsomes) are polymeric hollow capsules composed of a unique semipermeable membrane, which may represent a versatile platform for constructing drug-loaded nanoformulation. However, it is difficult to retain water-soluble low-molecular-weight compounds (LMWCs) in the inner space of PICsome because of the high permeability of PIC membrane for LMWCs. Herein, we selected mesoporous silica nanoparticle (MSN) as a drug-retaining nanomatrix, and we demonstrated successful encapsulation of MSN into the PICsome to obtain MSN@PICsome. The efficacy of MSN loading, a ratio of the amount of MSN encapsulated in the PICsome to the amount of feed MSN, was at most 83%, and the diameter of resulting product was approximately 100 nm. The obtained MSN@PICsome was stably dispersed under the physiological condition, and showed considerable longevity in blood circulation of mice. Furthermore, the surface of MSN in MSN@PICsome can be modified without any deterioration of the vesicle structure, obtaining amino-functionalized and sulfonate-functionalized MSN@PICsomes (A-MSN@PICsome and S-MSN@PICsome, respectively). Both surface-modified MSN@PICsomes were successfully loaded with charged water-soluble low-molecular-weight compounds (LMWCs). Particularly, S-MSN@PICsome kept 8 wt % gemcitabine (GEM) per S-MSN, and released it in a sustained manner. GEM-loaded S-MSN@PICsome demonstrated marked cytotoxicity against cultured tumor cells, and achieved significant in vivo efficacy to suppress the growth of subcutaneously implanted lung tumor via intravenous administration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Watarase Research Center, Kyorin Pharmaceutical CO., LTD., 1848, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan

Department of Chemistry, National Chung Hsing University, 250 Kuo-Kuang Road, Taichung 402, Taiwan

Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033 Japan

Innovation Center of NanoMedicne, Kawasaki Institute of Industry Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki 210-0821, Japan

Funding

Japan Society for the Promotion of Science · Japan Science and Technology Agency

References (49)

Show source-provided references
1. 10.1038/nrc156610.1038/nrc1566 ↗
2. 10.1038/nri348810.1038/nri3488 ↗
3. 10.1016/j.addr.2012.02.00210.1016/j.addr.2012.02.002 ↗
4. 10.1016/j.addr.2012.09.02310.1016/j.addr.2012.09.023 ↗
5. 10.1016/j.addr.2013.08.00510.1016/j.addr.2013.08.005 ↗
6. 10.1016/j.addr.2013.12.00910.1016/j.addr.2013.12.009 ↗
7. 10.1016/j.jconrel.2014.03.03010.1016/j.jconrel.2014.03.030 ↗
8. 10.1016/j.biotechadv.2013.10.01310.1016/j.biotechadv.2013.10.013 ↗
9. 10.1021/bm801127d10.1021/bm801127d ↗
10. 10.1039/c3py00023k10.1039/c3py00023k ↗
11. 10.1016/j.addr.2012.09.03710.1016/j.addr.2012.09.037 ↗
12. 10.1002/marc.20080071310.1002/marc.200800713 ↗
13. 10.1016/j.jconrel.2011.10.00510.1016/j.jconrel.2011.10.005 ↗
14. 10.1021/ja404175x10.1021/ja404175x ↗
15. 10.1002/anie.20131058910.1002/anie.201310589 ↗
16. 10.1038/pj.2013.3310.1038/pj.2013.33 ↗
17. 10.1021/ja057993r10.1021/ja057993r ↗
18. 10.1016/j.jconrel.2013.03.01610.1016/j.jconrel.2013.03.016 ↗
19. 10.1021/bm500127g10.1021/bm500127g ↗
20. 10.1021/ja908350e10.1021/ja908350e ↗
21. 10.1002/anie.20150833910.1002/anie.201508339 ↗
22. 10.1039/c1cc11465d10.1039/c1cc11465d ↗
23. 10.1039/c2cs15308d10.1039/c2cs15308d ↗
24. 10.1016/j.addr.2009.11.00810.1016/j.addr.2009.11.008 ↗
25. 10.1021/nl400681f10.1021/nl400681f ↗
26. 10.1021/cm801484r10.1021/cm801484r ↗
27. 10.1021/la402264610.1021/la4022646 ↗
28. 10.1002/anie.20080246910.1002/anie.200802469 ↗
29. 10.1016/j.apcata.2006.05.01110.1016/j.apcata.2006.05.011 ↗
30. 10.1021/cm300168810.1021/cm3001688 ↗
31. 10.1021/ja304907c10.1021/ja304907c ↗
32. 10.1007/s00280-004-0949-010.1007/s00280-004-0949-0 ↗
33. 10.1016/S0169-5002(05)81550-810.1016/S0169-5002(05)81550-8 ↗
34. 10.1093/jnci/95.5.34110.1093/jnci/95.5.341 ↗
35. 10.1517/14656566.3.6.74510.1517/14656566.3.6.745 ↗
36. 10.1016/j.jconrel.2009.07.00510.1016/j.jconrel.2009.07.005 ↗
37. 10.1016/j.jconrel.2010.02.02110.1016/j.jconrel.2010.02.021 ↗
38. 10.1016/j.biomaterials.2010.05.06010.1016/j.biomaterials.2010.05.060 ↗
39. 10.1021/bm101044h10.1021/bm101044h ↗
40. 10.1016/j.biomaterials.2013.01.06310.1016/j.biomaterials.2013.01.063 ↗
41. 10.1016/j.ijpharm.2012.02.01610.1016/j.ijpharm.2012.02.016 ↗
42. 10.1016/j.canlet.2012.08.02310.1016/j.canlet.2012.08.023 ↗
43. 10.1016/j.jconrel.2011.09.06610.1016/j.jconrel.2011.09.066 ↗
44. 10.1111/j.1151-2916.1995.tb08887.x10.1111/j.1151-2916.1995.tb08887.x ↗
45. 10.1021/ja309658710.1021/ja3096587 ↗
46. 10.1039/c3sm00089c10.1039/c3sm00089c ↗
47. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
48. 10.1016/j.jconrel.2014.06.04210.1016/j.jconrel.2014.06.042 ↗
49. 10.1016/j.addr.2014.06.00310.1016/j.addr.2014.06.003 ↗